Related Experiment Video
Updated: Aug 11, 2026

Using a GFP-tagged TMEM184A Construct for Confirmation of Heparin Receptor Identity
Published on: February 17, 2017
Identification of a new receptor subtype for tumor necrosis factor-alpha
D M Schwalb1, H M Han, M Marino
1Memorial Sloan-Kettering Cancer Center, New York, New York.
Abstract:
Two distinct receptors, which bind both tumor necrosis factor-alpha and tumor necrosis factor-beta (TNF-alpha and TNF-beta), have been previously identified and cloned from transformed cells. The present study identifies a novel receptor subtype in normal human liver which binds TNF-alpha but not TNF-beta. TNF-alpha but not TNF-beta competes for 125I-TNF-alpha binding and incorporation into affinity-labeled complexes in human liver plasma membranes (HLPM). Antisera to the cloned receptors competed for 125I-TNF-alpha binding to plasma membranes isolated from various transformed cell lines but not to HLPM. However, mRNAs corresponding in size to both known TNF receptors were detected in liver RNA, making it likely that post-transcriptional modifications account for the TNF-alpha specificity of HLPM. These observations suggest that the effects of TNF-alpha and TNF-beta on some normal tissues may be more distinct than previously realized.
Insights
Researchers discovered a new receptor in human liver that binds tumor necrosis factor-alpha (TNF-alpha) but not TNF-beta. This finding suggests distinct biological roles for these two crucial signaling molecules in normal tissues.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Two known receptors bind both tumor necrosis factor-alpha (TNF-alpha) and tumor necrosis factor-beta (TNF-beta) and have been identified in transformed cells.
- TNF-alpha and TNF-beta are key cytokines involved in inflammation, immune response, and cell death.
Purpose of the Study:
- To identify and characterize novel TNF receptor subtypes in normal human tissues.
- To investigate the binding specificity of TNF receptors in normal human liver plasma membranes (HLPM).
Main Methods:
- Utilized radioligand binding assays with 125I-TNF-alpha to assess receptor interactions.
- Employed competition assays using TNF-alpha and TNF-beta to determine binding specificity.
- Analyzed mRNA expression of known TNF receptors in liver tissue.
- Used antisera against cloned TNF receptors to probe HLPM.
Main Results:
- Identified a novel receptor subtype in HLPM that binds TNF-alpha exclusively, not TNF-beta.
- TNF-alpha, but not TNF-beta, competed for 125I-TNF-alpha binding to HLPM.
- Antisera to known receptors did not inhibit binding to HLPM, unlike in transformed cell lines.
- mRNA for both known TNF receptors was present in liver RNA, suggesting post-transcriptional regulation.
Conclusions:
- Normal human liver expresses a unique TNF receptor with specificity for TNF-alpha.
- Post-transcriptional modifications likely account for the observed TNF-alpha specificity in HLPM.
- TNF-alpha and TNF-beta may exert more distinct biological effects on normal tissues than previously understood.
More Related Videos
Related Concept Videos
Enzyme-linked Receptors
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Receptor Tyrosine Kinases
TGF - β Signaling Pathway
Transducer Mechanism: Enzyme-Linked Receptors
Major types that are helpful drug targets include:

